Gsk Pharma India Private Limited, a active private limited company, was established on 02 June 2000 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239MH2000PTC126937. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹12.80 Cr and a paid-up capital of ₹7.68 Cr.
Formerly known as Stiefel India Private Limited. It upholds a compliant status. Its leadership includes Ayush Kumar (Director), Ajay Avinash Nadkarni (Director). Past directors included Ronojit Biswas, Wong Tsui Ling, Sushil Khanna. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1, Battery House , Bhulabhai Desai Road, Mumbai, Maharashtra, 400026.
U24239MH2000PTC126937
126937
02 June 2000
₹12.80 Cr
₹7.68 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Gsk Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayush Kumar | Director | 15 Jan 2024 | Current |
| Ajay Avinash Nadkarni | Director | 03 Jan 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 31 Aug 2019 | Past |
| Pramod Abcsdd | Director | 31 Dec 2010 | Past |
| Pramod Abcsdd | Director | 30 Nov 2016 | Past |
| Pramod Abcsdd | Director | 17 Jul 2009 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gsk Pharma India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.33% increase. The company also saw a substantial improvement in profitability, with a 12.65% increase in profit. The company's net worth Soared by an impressive increase of 34.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Gsk Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gsk Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gsk Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gsk Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gsk Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Gsk Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Ayush Kumar was appointed as a Director was appointed as a Director on 15 Jan 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The activity Ajay Avinash Nadkarni was appointed as a Director was appointed as a Director on 03 Jan 2011 & has been associated with this company since 14 years 10 months . was completed.
Progress on Gsk Pharma India Private Limited was registered on 02 Jun 2000 with Roc Mumbai & aged 25 years 6 months as per MCA records. was documented.
The CIN of Gsk Pharma India Private Limited is U24239MH2000PTC126937.
Gsk Pharma India Private Limited is headquartered at 1, Battery House , Bhulabhai Desai Road, Mumbai, Maharashtra, 400026.
Gsk Pharma India Private Limited was incorporated on 02 June 2000.
The current directors of Gsk Pharma India Private Limited are
The primary industry of Gsk Pharma India Private Limited is Trade.
Gsk Pharma India Private Limited is unlisted.
The authorized capital of Gsk Pharma India Private Limited is ₹12.80 Cr, and the paid-up capital is ₹7.68 Cr.
The compliance status of Gsk Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX